Documents/HHSFACA878

FACA Committee Purpose & Justification

Strategic_Plan

Start: 2010-10-01, End: 2011-09-30, Publication: 2013-07-09

Source: http://explore.data.gov/resource/datasets/c5i3-bb9j

The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML Part 1, Strategic Plan, format.

Fiscal Year:2011 Committee Type: Scientific Technical Program Advisory Board

Submitter:

Name:Gannon (J.) Dick

Email:gannon_dick@yahoo.com

Organization:

Name:Advisory Committee for Pharmaceutical Science and Clinical Pharmacology

Acronym:HHS

Description:
[878]: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/default.htm

Stakeholder(s):

  • Department of Health and Human Services[32]: http://www.hhs.gov/
    • Sponsoring Agency (Beneficiary)

  • Dr Mukul Agrawal PhDRoxane Laboratories, Inc
    • Committee Member (Performer)Representative

  • Jessie L-S Au PhDDistinguished University Professor, The Ohio State University
    • Committee Member (Performer)Special Government Employee (SGE)

  • Jeffrey S. Barrett Ph.D.Associate Professor, Pediatrics, Children's Hospital of Philadelphia
    • Committee Member (Performer)Special Government Employee (SGE)

  • Prabir K. Basu Ph.D., MBAExecutive Director, National Insitute for Technology and Education
    • Committee Member (Performer)Special Government Employee (SGE)

  • Michael D. Caldwell M.D., Ph.DDirector, Wound Healing Program, Marshfield Clinic Research Foundation
    • Committee Member (Performer)Special Government Employee (SGE)

  • Edmund V. Capparelli Pharm.D.Associate Clinical Professor, Pediatric Pharmacology Research Unit, University of California, San Diego,
    • Committee Member (Performer)Special Government Employee (SGE)

  • Jerry M. Collins Ph.D.Associate Director for Developmental Therapeutics, NCI, NIH, Division of Cancer Treatment and Diagnosis
    • Committee Member (Performer)Regular Government Employee (RGE)

  • David A. Flockhart Ph.D.Professor and Chief, Division of Clinical Pharmacology, Indiana University
    • Committee Member (Performer)Special Government Employee (SGE)

  • Kathleen M. Giacomini Ph.D.Chair, Dept. of Biopharmaceutical Sciences, University of California School of Pharmacy
    • Committee Member (Performer)Special Government Employee (SGE)

  • Merrill GooznerDirector of Integrity and Science Project, Washington, D.C.
    • Committee Member (Performer)Special Government Employee (SGE)

  • Arthur F. Harralson Pharm.D.Associate Dean for Academic Affairs, Shenandoah University School of Pharmacy
    • Committee Member (Performer)Special Government Employee (SGE)

  • Gregory L. Kearns Ph.D.Professor of Pediatrics and Pharmacology, Children's Mercy Hospitals and Clinics
    • Committee Member (Performer)Special Government Employee (SGE)

  • Juan J.L. Lertora M.D., Ph.DDirector, Clinical Pharmacology Program
    • Committee Member (Performer)Regular Government Employee (RGE)

  • Donald E. Mager Ph.D.Assistant Professor of Pharmaceutical Sciences, University of Buffalo, SUNY
    • Committee Member (Performer)Special Government Employee (SGE)

  • Dr Philip Mayer PhDWyeth Research
    • Committee Member (Performer)Representative

  • Howard L. McLeod Pharm.D.Director, Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill
    • Committee Member (Performer)Special Government Employee (SGE)

  • Fernando J Muzzio Ph.DProfessor of Chemical Engineering, Department of Chemical and Biochemistry, Rutgers University
    • Committee Member (Performer)Special Government Employee (SGE)

  • Harriet B Nembhard Ph.D.Associate Professor, Pennsylvania State University
    • Committee Member (Performer)Special Government Employee (SGE)

  • James E. Polli Ph.D.Professor and Vice-Chair
    • Committee Member (Performer)Special Government Employee (SGE)

  • Mary V. Relling Pharm.D.Chair, Pharmaceutical Department, St. Jude Children's Research Hospital
    • Committee Member (Performer)Special Government Employee (SGE)

  • Anne Skaja Robinson PhDAssociate Professor, University of Delaware
    • Committee Member (Performer)Special Government Employee (SGE)

  • Fadia T. Shaya Ph.D., MPHAssociate Professor, University of Maryland School of Pharmacy, Dept. of Pharmaceutical Health Services Research
    • Committee Member (Performer)Special Government Employee (SGE)

  • Dr Richard Stec, Jr PhDHospira, Inc.
    • Committee Member (Performer)Representative

  • Elizabeth M. Topp Ph.D.Head, Department of Industrial and Physical Pharmacy, Purdue University
    • Committee Member (Performer)Special Government Employee (SGE)

  • Dr Patricia Tway PhDCMC Technical Navigator
    • Committee Member (Performer)Representative

  • Jurgen Venitz M.D., Ph.DAssoicate Professor, Virginia Commonwealth University School of Pharmacy, Department of Pharmaceutics
    • Committee Member (Performer)Special Government Employee (SGE)